Please login to the form below

Not currently logged in
Email:
Password:

Norgine moves to raise awareness of head and neck cancer procedure

Partners with the Make Sense campaign on sentinel lymph node mapping work

NorgineNorgine has partnered with the European Head and Neck Society (EHNS) on its Make Sense Campaign to help raise awareness of sentinel lymph node biopsy, mapping and identification in head and neck cancer treatment.

The partners also intend to highlight the importance of nuclear medicine as a critical part of the multi-disciplinary team.

Dr Alastair Benbow, chief development and medical officer for Norgine, said: “As a patient-centric company, we are committed to improving the treatment of patients with head and neck cancer.

“Through this important collaboration we aim to increase awareness of the role that sentinel lymph node mapping can play in identifying tumours in the head and neck, to ensure the most appropriate treatment is chosen.”

The new initiative will build on EHNS’ established Make Sense campaign, which aims to raise awareness of head and neck cancer across Europe, South Korea and India.

Campaign activities are focused on educating healthcare professionals (HCPs) and the general public on disease prevention, including signs and symptoms, which aims to drive earlier presentation, diagnosis and referral.

EHNS president René Leemans said: “Head and neck cancer is the seventh most common type of cancer in Europe, and its incidence is increasing.

“Through this partnership we hope to continue to address head and neck cancer unmet needs by improving healthcare professional understanding of the evolving treatment landscape consequently improving patient outcomes,” he concluded.

The campaign will also place additional focus on educating HCPs about sentinel lymph node mapping in head and neck cancer to ensure better treatment plans and patient care.

Article by
Gemma Jones

17th July 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics